GPX2 and lung adenocarcinoma: In fact, it has been reported that silencing GPX2 partially reverses erastin-induced ferroptosis in lung adenocarcinoma, indicating a potential role of GPX2 as a ferroptosis driver in lung adenocarcinoma (44).